Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Vericel (VCEL) over the last 15 years, with Sep 2025 value amounting to $3.5 million.

  • Vericel's Change in Accured Expenses rose 133.80% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 459.29%. This contributed to the annual value of $205,000 for FY2024, which is 80.00% down from last year.
  • According to the latest figures from Q3 2025, Vericel's Change in Accured Expenses is $3.5 million, which was up 16.47% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Vericel's Change in Accured Expenses registered a high of $3.6 million during Q4 2023, and its lowest value of -$6.2 million during Q1 2024.
  • In the last 3 years, Vericel's Change in Accured Expenses had a median value of $1.5 million in 2024 and averaged $186,636.
  • Examining YoY changes over the last 5 years, Vericel's Change in Accured Expenses showed a top increase of 1,351.72% in 2022 and a maximum decrease of 181.17% in 2022.
  • Quarterly analysis of 5 years shows Vericel's Change in Accured Expenses stood at $3.1 million in 2021, then decreased by 27.98% to $2.2 million in 2022, then spiked by 59.99% to $3.6 million in 2023, then dropped by 13.80% to $3.1 million in 2024, then soared by 133.80% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $3.0 million for Q2 2025, and -$5.7 million during Q1 2025.